2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Neoplasm Metastasis
1
Insulin Resistance
1
Hyperandrogenism
1
Glucose Intolerance
1
Endometrial Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma
1
Anovulation
1
Anastomotic Leak
1
Adenomatous Polyposis Coli
1
Interventions
Metformin
30
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
5
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Surveys and Questionnaires
2
Sugars
2
Resistance Training
2
Preoperative Exercise
2
Observation
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Cholecalciferol
2
Caloric Restriction
2
Biguanides
2
ziprasidone
1
maltodextrin
1
lime
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Insulin Resistance
×
Inulin
×
Clear all
NCT03864068
2026-01-07
INSUPP-PCOS
Milton S. Hershey Medical Center
Phase 2
Completed
154 enrolled